Philip C Kendall1, Colleen M Cummings1, Marianne A Villabø2, Martina K Narayanan3, Kimberli Treadwell4, Boris Birmaher5, Scott Compton6, John Piacentini7, Joel Sherrill8, John Walkup9, Elizabeth Gosch10, Courtney Keeton11, Golda Ginsburg11, Cindy Suveg12, Anne Marie Albano13. 1. Department of Psychology, Temple University. 2. Department of Psychology, Center for Child and Adolescent Mental Health. 3. Department of Psychology, The Norwegian Center for Child Behavioral Development. 4. Department of Psychology, University of Connecticut. 5. Department of Psychiatry, University of Pittsburgh. 6. Department of Psychiatry and Behavioral Sciences, Duke University. 7. Department of Psychiatry and Behavioral Sciences, University of California, Los Angeles. 8. Child and Adolescent Mental Health, National Institute of Mental Health. 9. Department of Child and Adolescent Psychiatry, Cornell University. 10. Department of Psychology, Philadelphia College of Osteopathic Medicine. 11. Department of Child and Adolescent Psychiatry, Johns Hopkins University. 12. Department of Psychology, University of Georgia. 13. Department of Child and Adolescent Psychiatry, Columbia University.
Abstract
OBJECTIVE: Test changes in (a) coping efficacy and (b) anxious self-talk as potential mediators of treatment gains at 3-month follow-up in the Child/Adolescent Anxiety Multimodal Treatment Study (CAMS). METHOD: Participants were 488 youth (ages 7-17; 50.4% male) randomized tocognitive-behavioral therapy (CBT; Coping cat program), pharmacotherapy (sertraline), their combination, or pill placebo. Participants met Diagnostic and Statistical Manual for Mental Disorders-Fourth Edition (DSM-IV) criteria for generalized anxiety disorder, social phobia, and/or separation anxiety disorder. Coping efficacy (reported ability to manage anxiety provoking situations) was measured by youth and parent reports on the Coping Questionnaire, and anxious self-talk was measured by youth report on the Negative Affectivity Self-Statement Questionnaire. Outcome was measured using the Pediatric Anxiety Rating Scale (completed by Independent Evaluators blind to condition). For temporal precedence, residualized treatment gains were assessed at 3-month follow-up. RESULTS: Residualized gains in coping efficacy mediated gains in the CBT, sertraline, and combination conditions. In the combination condition, some unique effect of treatment remained. Treatment assignment was not associated with a reduction in anxious self-talk, nor did anxious self-talk predict changes in anxiety symptoms. CONCLUSIONS: The findings suggest that improvements in coping efficacy are a mediator of treatment gains. Anxious self-talk did not emerge as a mediator. (c) 2015 APA, all rights reserved).
RCT Entities:
OBJECTIVE: Test changes in (a) coping efficacy and (b) anxious self-talk as potential mediators of treatment gains at 3-month follow-up in the Child/Adolescent Anxiety Multimodal Treatment Study (CAMS). METHOD:Participants were 488 youth (ages 7-17; 50.4% male) randomized to cognitive-behavioral therapy (CBT; Coping cat program), pharmacotherapy (sertraline), their combination, or pill placebo. Participants met Diagnostic and Statistical Manual for Mental Disorders-Fourth Edition (DSM-IV) criteria for generalized anxiety disorder, social phobia, and/or separation anxiety disorder. Coping efficacy (reported ability to manage anxiety provoking situations) was measured by youth and parent reports on the Coping Questionnaire, and anxious self-talk was measured by youth report on the Negative Affectivity Self-Statement Questionnaire. Outcome was measured using the Pediatric Anxiety Rating Scale (completed by Independent Evaluators blind to condition). For temporal precedence, residualized treatment gains were assessed at 3-month follow-up. RESULTS: Residualized gains in coping efficacy mediated gains in the CBT, sertraline, and combination conditions. In the combination condition, some unique effect of treatment remained. Treatment assignment was not associated with a reduction in anxious self-talk, nor did anxious self-talk predict changes in anxiety symptoms. CONCLUSIONS: The findings suggest that improvements in coping efficacy are a mediator of treatment gains. Anxious self-talk did not emerge as a mediator. (c) 2015 APA, all rights reserved).
Authors: Philip C Kendall; Scott N Compton; John T Walkup; Boris Birmaher; Anne Marie Albano; Joel Sherrill; Golda Ginsburg; Moira Rynn; James McCracken; Elizabeth Gosch; Courtney Keeton; Lindsey Bergman; Dara Sakolsky; Cindy Suveg; Satish Iyengar; John March; John Piacentini Journal: J Anxiety Disord Date: 2010-02-06
Authors: Scott N Compton; John T Walkup; Anne Marie Albano; John C Piacentini; Boris Birmaher; Joel T Sherrill; Golda S Ginsburg; Moira A Rynn; James T McCracken; Bruce D Waslick; Satish Iyengar; Phillip C Kendall; John S March Journal: Child Adolesc Psychiatry Ment Health Date: 2010-01-05 Impact factor: 3.033
Authors: Krystal M Lewis; Chika Matsumoto; Elise Cardinale; Emily L Jones; Andrea L Gold; Argyris Stringaris; Ellen Leibenluft; Daniel S Pine; Melissa A Brotman Journal: J Child Adolesc Psychopharmacol Date: 2020-03-11 Impact factor: 2.576
Authors: Jerome H Taylor; Eli R Lebowitz; Ewgeni Jakubovski; Catherine G Coughlin; Wendy K Silverman; Michael H Bloch Journal: J Clin Child Adolesc Psychol Date: 2017-09-28
Authors: Armando A Pina; Nancy A Gonzales; Gina L Mazza; Heather J Gunn; Lindsay E Holly; Ryan D Stoll; Julia Parker; Amanda Chiapa; Henry Wynne; Jenn-Yun Tein Journal: Prev Sci Date: 2020-05
Authors: Anna J Swan; Philip C Kendall; Thomas Olino; Golda Ginsburg; Courtney Keeton; Scott Compton; John Piacentini; Tara Peris; Dara Sakolsky; Boris Birmaher; Anne Marie Albano Journal: J Consult Clin Psychol Date: 2018-09
Authors: Amy E Hale; Golda S Ginsburg; Grace Chan; Philip C Kendall; James T McCracken; Dara Sakolsky; Boris Birmaher; Scott N Compton; Anne Marie Albano; John T Walkup Journal: J Clin Child Adolesc Psychol Date: 2017-02-26